title: Paroxysmal nocturnal haemoglobinuria following breast cancer radiotherapy.
authors.affiliation: e de Médecine Interne, 264 rue Saint-Pierre, 13385 Marseille Cedex 5, France.
authors.forename: Brigitte
authors.initials: B
authors.lastname: Granel
authors.forename: Jacques
authors.initials: J
authors.lastname: Serratrice
authors.forename: Martine
authors.initials: M
authors.lastname: David
authors.forename: Chantal
authors.initials: C
authors.lastname: Fossat
authors.forename: Patrick
authors.initials: P
authors.lastname: Disdier
authors.forename: Pierre-Jean
authors.initials: PJ
authors.lastname: Weiller
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D000743:Anemia, Hemolytic / Q000209:etiology / Q000628:therapy; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D002277:Carcinoma / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D006457:Hemoglobinuria, Paroxysmal / Q000209:etiology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008408:Mastectomy; D008875:Middle Aged; D016609:Neoplasms, Second Primary; D010051:Ovarian Neoplasms / Q000601:surgery; D010052:Ovariectomy; D011878:Radiotherapy / Q000009:adverse effects*; D013629:Tamoxifen / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D016756:Immunoglobulins, Intravenous; D013629:Tamoxifen